| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 03/29/2001 | WO2001021216A1 Capsid-modified recombinant adenovirus and methods of use |
| 03/29/2001 | WO2001021200A1 Oral recombinant lactobacilli vaccines |
| 03/29/2001 | WO2001000843A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 03/29/2001 | WO2000077026A8 49 human secreted proteins |
| 03/29/2001 | DE19946296A1 Multiplex-PCR zum Nachweis von EHEC-Infektionen Multiplex PCR for detection of EHEC infections |
| 03/29/2001 | DE19937548A1 Ein- oder mehrzellige Organismen zur Herstellung von Riboflavin Mono- or multicellular organisms for the production of riboflavin |
| 03/29/2001 | CA2385497A1 Methods and microorganisms for production of panto-compounds |
| 03/29/2001 | CA2384827A1 Capsid-modified recombinant adenovirus and methods of use |
| 03/29/2001 | CA2383433A1 Oral recombinant lactobacilli vaccines |
| 03/29/2001 | CA2319213A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof |
| 03/28/2001 | EP1087015A2 Cloning and uses of a novel nucleotide sequence coding for glucose-6-phosphate isomerase (gpi) from bacteria |
| 03/28/2001 | EP1087014A1 Hog cholera virus vaccine and diagnostic |
| 03/28/2001 | EP1087013A2 Immunoglobulins devoid of light chains |
| 03/28/2001 | EP1086240A1 Methods for testing biological network models |
| 03/28/2001 | EP1086238A1 Human mp52 gene promoter and method for exploring useful substance by using the same |
| 03/28/2001 | EP1086231A2 ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220 |
| 03/28/2001 | EP1086230A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs |
| 03/28/2001 | EP1086211A2 Novel mannanases |
| 03/28/2001 | EP1086210A1 Novel mannanases |
| 03/28/2001 | EP1086209A2 Fy7 polymerase |
| 03/28/2001 | EP1086138A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 03/28/2001 | EP1086136A1 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples |
| 03/28/2001 | EP1085882A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
| 03/28/2001 | CN1063796C Preparation method for drythropoietin isoforms |
| 03/28/2001 | CN1063795C Method for production of glucagon |
| 03/28/2001 | CN1063792C Hamanized antibodies and uses thereof |
| 03/27/2001 | US6207818 Amplification and detection of shigella spp. and enteroinvasive strains of Escherichia coli |
| 03/27/2001 | US6207814 Activin receptor-like kinases, ALK-3 and ALK-6, and nucleic acids encoding them |
| 03/27/2001 | US6207811 Nephrin gene and protein |
| 03/27/2001 | US6207806 IGF-I purification process |
| 03/27/2001 | US6207805 Hybridoma which secretes monoclonal antibodies; diagnosis; anticarcinogenic agents with reduced side effects; imaging |
| 03/27/2001 | US6207804 Genetically engineered antibody analogues and fusion proteins thereof |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207802 Non-human, mammalian polypeptide of defined amino acid sequence which activates the growth of early hematopoietic progenitor cells; treatment of blood disorders; anticarcinogenic agents; bone marrow regeneration |
| 03/27/2001 | US6207647 Polynucleotides and polypeptides of the rat family, referred to as ?rata?; treatment of chlamydia infections |
| 03/27/2001 | US6207453 A replication-defective adeno-associated virus vector containing exogenous dna bound to a dna which codes for a rep protein; gene therapy |
| 03/27/2001 | US6207449 Nucleotide sequence of gene; hybridization probes for detection; drug screening for bactericides, bacteriostats and antibiotics |
| 03/27/2001 | US6207435 Method for producing nucleoside-5′-phosphate ester |
| 03/27/2001 | US6207428 Process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof from the fermentation broth of streptomyces sp. P 6621 FERM P 2804 |
| 03/27/2001 | US6207417 DNA encoding stem cell factor |
| 03/27/2001 | US6207411 Bacteriocins |
| 03/27/2001 | US6207409 Culturing a recombinant cell that has been transformed with an expression vector having a regulatory sequence and a polynucleotide comprising a dna sequence which endcodes geranyl/geranylpyrophosphate of flavobacterium species |
| 03/27/2001 | US6207374 Tuberous sclerosis 2 gene and uses thereof |
| 03/27/2001 | US6207169 Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| 03/27/2001 | US6207158 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 03/27/2001 | US6207152 Anticancer agent |
| 03/27/2001 | US6207146 Gene expression in mammalian cells |
| 03/27/2001 | CA2135200C Canine coronavirus s gene and uses therefor |
| 03/27/2001 | CA2123107C Ubiquitin-specific proteases |
| 03/27/2001 | CA2076540C Recombinant antibodies specific for tnf-.alpha. |
| 03/27/2001 | CA2008304C Assay for bone alkaline phosphatase |
| 03/27/2001 | CA1341211C Mini-proinsulin, its preparation and use |
| 03/27/2001 | CA1341208C Proteins with factor viii activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them |
| 03/24/2001 | CA2283376A1 Synthesis of optically active phenylalanine analogs through microbial transformations |
| 03/22/2001 | WO2001020013A2 Viral replicons and viruses dependent on inducing agents |
| 03/22/2001 | WO2001019974A2 Recombinant microorganisms |
| 03/22/2001 | WO2001019960A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | WO2001019870A2 Secreted soluble alpha2delta-2, alpha2delta-3, alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/22/2001 | WO2001019840A1 Pesticidal macrolides |
| 03/22/2001 | WO2001019182A1 Nuclear transfer with selected donor cells |
| 03/22/2001 | WO2000077260A8 Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms |
| 03/22/2001 | WO2000067696A3 Lactic acid bacteria with anxiolytic properties and uses thereof |
| 03/22/2001 | WO2000063240A9 ANTIFUNGAL AGENTS ISOLATED FROM $i(PSEUDOMONAS SYRINGAE) |
| 03/22/2001 | WO2000059943A3 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE |
| 03/22/2001 | WO2000045840A8 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence |
| 03/22/2001 | WO1999058678A9 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 03/22/2001 | CA2386530A1 Viral replicons and viruses dependent on inducing agents |
| 03/22/2001 | CA2385308A1 Secreted soluble alpha2delta-2, alpha2delta-3, or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/22/2001 | CA2384081A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | CA2382067A1 Recombinant microorganisms |
| 03/21/2001 | EP1085098A2 A composition for providing long term stability to cells for diagnostic testing |
| 03/21/2001 | EP1085096A2 Preparation of high trehalose content product |
| 03/21/2001 | EP1085095A1 Synthesis of optically active phenylalanine analogs through microbial transformations |
| 03/21/2001 | EP1085094A2 Nucleotide sequences which code for the dapF gene |
| 03/21/2001 | EP1085091A1 Nucleotide sequences coding for thrE-gene and process for the fermentative preparation of L-threonine using coryneform bacteria |
| 03/21/2001 | EP1085089A2 Human cyclic nucleotide phosphodiesterase |
| 03/21/2001 | EP1085088A1 Monoclonal antibodies and method for assaying fdp |
| 03/21/2001 | EP1085087A2 Method for producing amino acids by fermentation using aminoquinoline resistant bacterial strains |
| 03/21/2001 | EP1085086A2 Method for producing amino acids by fermentation using DNA gyrase inhibitor resistant bacterial strains |
| 03/21/2001 | EP1084709A1 Oral recombinant lactobacilli vaccines |
| 03/21/2001 | EP1084268A1 Biotechnological production of polyglutaminic acid |
| 03/21/2001 | EP1084262A1 Promoter and constructions for expression of recombinant proteins in filamentous fungi |
| 03/21/2001 | EP1084258A1 Industrial method for producing heterologous proteins in e.coli and strains useful for said method |
| 03/21/2001 | EP1084141A1 nrdF |
| 03/21/2001 | EP1083928A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases |
| 03/21/2001 | EP0865495A4 Progestin-regulated gene |
| 03/21/2001 | EP0734529B1 Methods and materials for the detection of staphylococcus aureus |
| 03/21/2001 | EP0547201B1 Phagemide for screening antibodies |
| 03/21/2001 | EP0539518B1 Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction |
| 03/21/2001 | CN1288061A Method for prepn. of D-pantothenic acid using bar shaped bacteria fermentation |
| 03/21/2001 | CN1288060A Reproduced freely particles in bar shaped bacteria |
| 03/21/2001 | CN1288058A Novel nucleotide series with coded pgi gene |
| 03/21/2001 | CN1288055A Novel nucleotide series with coded dapF gene |
| 03/20/2001 | US6204367 Elisa kit for quantification of C-terminal telopeptides of type I collagen in human serum |
| 03/20/2001 | US6204366 Specific binding agents |
| 03/20/2001 | US6204362 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 03/20/2001 | US6204241 Polypeptides found in vertebrate species, which polypeptides are mitogenic growth factors for glial cells, including schwann cells. |
| 03/20/2001 | US6204057 Polynucleotides and the proteins encoded thereby, suitable for controlling lamellicorn beetles |
| 03/20/2001 | US6204053 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |